Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
R&D Collaborations
Filter     Order     Display # 
Date Item Title
19 Aug 2008 Affitech and Omeros Enter Into Antibody Discovery and Development Agreement
19 Aug 2008 Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy
19 Aug 2008 EndoBiologics, Incorporated, and PATH Form New Collaboration to Research Vaccine Candidates Against Diarrheal Disease
16 Aug 2008 AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds
14 Aug 2008 Tekmira Pharmaceuticals Announces RNAi Research Collaboration with Bristol-Myers Squibb
14 Aug 2008 Karo Bio and Wyeth Extend Research Collaboration
11 Aug 2008 Alnylam Forms Collaboration with Max Planck Institute to Investigate Biological Mechanisms for Cellular Uptake of RNAi Therapeutics
10 Aug 2008 Metabasis Therapeutics Announces Collaboration with Roche to Develop Liver-Targeted Compounds for the Treatment of Hepatitis C
06 Aug 2008 Capricorn Pharma Inc. and TEVA Pharmaceuticals USA (TEVA) Enter Into Agreement
05 Aug 2008 Regeneron Announces VelociGene(R) Agreement with Sanofi-Aventis
26 Jul 2008 GlaxoSmithKline and the Harvard Stem Cell Institute announce a unique collaboration to enable the discovery of new medicines
21 Jul 2008 Cenix BioScience GmbH Signs Research Agreement with Regulus Therapeutics (JOBS) for miRNA-Targeted Drug Discovery
19 Jul 2008 Galapagos announces first milestone in osteoporosis collaboration with Lilly
17 Jul 2008 EpiCept and GNI Partner to Develop Anti-Viral Hepatitis Drug in Asia
16 Jul 2008 Alnylam Announces Extension of RNAi Therapeutics Collaboration with Novartis
15 Jul 2008 Lonza and Kyowa Hakko extend their strategic collaboration
09 Jul 2008 Boehringer Ingelheim Gains Access to Additional MorphoSys Technology
08 Jul 2008 Seattle Genetics Announces Antibody-Drug Conjugate Collaboration with Daiichi Sankyo
01 Jul 2008 Palatin Technologies Announces Amendment Expanding AstraZeneca Obesity Collaboration
01 Jul 2008 Sciele Pharma Signs Agreement with Addrenex Pharmaceuticals To Develop and Market ADX415 for the Treatment of Hypertension
29 Jun 2008 Exelixis and GlaxoSmithKline Agree to Successfully Conclude Six-Year Discovery and Development Collaboration
29 Jun 2008 Dako Enters into Collaboration with Bristol-Myers Squibb for Pharmacodiagnostics
24 Jun 2008 Novartis Institute for Tropical Diseases and Global Alliance for TB Drug Development announce five-year collaboration targeted to accelerate TB treatment R&D
22 Jun 2008 Cytokinetics Announces Third Extension of Research Term Under Collaboration with GlaxoSmithKline
19 Jun 2008 Nuevolution Announces Research and Development Collaboration with Merck & Co., Inc. (MRK)
19 Jun 2008 Merck Serono and Bionomics Announce Multiple Sclerosis Development and Licensing Agreement
17 Jun 2008 AstraZeneca and Columbia University Medical Center Sign Strategic Research Collaboration to Develop Novel Therapeutics for Diabetes and Obesity
16 Jun 2008 OncoMed Pharmaceuticals Extends License Agreement for Use of MorphoSys's Core Technology
16 Jun 2008 Alligator Bioscience AB and PolyTherics Ltd announce strategic collaboration for optimisation of next generation biopharmaceuticals
16 Jun 2008 GlaxoSmithKline and Mpex Pharmaceuticals form alliance to develop novel efflux pump inhibitors for use against serious gram-negative infections
11 Jun 2008 Cellectricon and AstraZeneca - partners in new high throughput ion channel drug discovery technology
10 Jun 2008 Astex Announces New Drug Discovery Alliance with Janssen Pharmaceutica N.V.
10 Jun 2008 Symphogen Enters into strategic collaboration with Genentech for antibody thera-peutics
10 Jun 2008 Pfizer and UCSF Form Alliance to Advance a Broad Range of Research
30 May 2008 Locus Pharmaceuticals Initiates Strategic Inflammatory Cancer Research Collaborations
27 May 2008 Alnylam and Takeda Form Strategic Worldwide Platform Alliance in RNAi TherapeuticsAlnylam and Takeda Form Strategic Worldwide Platform Alliance in RNAi Therapeutics
26 May 2008 GVK BIO enters into Drug Discovery Pact with Wyeth Pharmaceuticals
22 May 2008 Medistem Laboratories, Inc. and Orcist Bio Inc. Enter Into Collaboration Agreement Focused on Augmenting Stem Cell Activity
22 May 2008 ThalesNano Inc. and sanofi-aventis R&D collaborate on continuous process chemistry in order to dramatically reduce drug realization time
21 May 2008 BioSeek to Collaborate with Merck Serono to Assess Potential Drug Candidates
20 May 2008 Five Prime and Pfizer enter Oncology and Diabetes Collaboration
19 May 2008 Schering-Plough Extends Antibody Alliance with MorphoSys
15 May 2008 Medivir AB broadens its Hepatitis C collaboration with Tibotec, entering a partnership in the fiels of HCV Polymerase
12 May 2008 Ranbaxy & Merck Sign Anti-infective Drug Discovery And Development Agreement
08 May 2008 Cytopia announces novel anti-cancer drug development collaboration
08 May 2008 LFB Biotechnologies and GTC Biotherapeutics to collaborate on rhAAT program
07 May 2008 Champions Biotechnology and ImClone Systems Establish Agreement for Preclinical Evaluation of Oncology Drugs
24 Apr 2008 Arana and Kyowa Hakko to co-develop anti-cancer drug
24 Apr 2008 MorphoSys and the Leibniz-Institut für Molekulare Pharmakologie Sign Broad Research Partnership
23 Apr 2008 Metabasis Therapeutics Announces Extension of Its Collaboration with Merck & Co., Inc. to Develop AMPK Activators for Diabetes and Other Metabolic Diseases
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 1 - 50 of 508

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Thrombopoiesis-Stimulating Agents (TPO)

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics